Similarity and Robustness of PET and SPECT Binding Parameters for Benzodiazepine Receptors
暂无分享,去创建一个
B Walder | G Westera | A Buck | A. Buck | D. Slosman | P Millet | M Arigoni | C Broggini | G. Westera | C Graf | D Slosman | C Bouras | V Ibáñez | M. Arigoni | V. Ibáñez | P. Millet | Christophe Graf | Bernard Walder | Claudia Broggini | Constantin Bouras | Claudia Broggini
[1] C Crouzel,et al. Quantification of Benzodiazepine Receptors in Human Brain Using PET, [11C]Flumazenil, and a Single-Experiment Protocol , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] Keiichi Oda,et al. Preserved benzodiazepine receptors in Alzheimer’s disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF , 1999, Annals of nuclear medicine.
[3] L Cinotti,et al. Parameter and index images of benzodiazepine receptor concentration in the brain. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] J. Seibyl,et al. SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] Z Rattner,et al. Measurement of Benzodiazepine Receptor Number and Affinity in Humans Using Tracer Kinetic Modeling, Positron Emission Tomography, and [11C]Flumazenil , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] J. Mazziotta,et al. Rapid Automated Algorithm for Aligning and Reslicing PET Images , 1992, Journal of computer assisted tomography.
[7] J. Baron,et al. Regional Specific Binding of [11C]RO 15 1788 to Central Type Benzodiazepine Receptors in Human Brain: Quantitative Evaluation by PET , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] J. Baron,et al. Central benzodiazepine receptors in human brain: estimation of regional Bmax and KD values with positron emission tomography. , 1992, European journal of pharmacology.
[9] D. Marquardt. An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .
[10] E. Sybirska,et al. Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[11] J. Baron,et al. A comparison of methods for the separation of [11C]Ro 15-1788 (flumazenil) from its metabolites in the blood of rabbits, baboons and humans. , 1991, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.
[12] J Delforge,et al. Concept of reaction volume in the in vivo ligand-receptor model. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] J. Mazziotta,et al. MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.
[14] G A Clarke,et al. Clinical experience with a multidetector SPET system (Toshiba GCA‐9300A) , 1994, Nuclear medicine communications.
[15] P B Hoffer,et al. Single photon emission tomography measurement of benzodiazepine receptor number and affinity in primate brain: a constant infusion paradigm with [123I]iomazenil. , 1993, European journal of pharmacology.
[16] S. Mallat. A wavelet tour of signal processing , 1998 .
[17] W. Haefely,et al. Co-localization of GABAA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies , 1985, Nature.
[18] N L Foster,et al. Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. , 1995, Archives of neurology.
[19] W. Haefely. Biochemistry of anxiety. , 1985, Annals of the Academy of Medicine, Singapore.
[20] G A Clarke,et al. Physical performance evaluation of the Toshiba GCA-9300A triple-headed system. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] W. Haefely. Pharmacology of Benzodiazepine Antagonists , 1985, Pharmacopsychiatry.
[22] R. Koeppe,et al. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain , 1991, Annals of neurology.
[23] O. Muzik,et al. Altered In Vitro and In Vivo Flumazenil Binding in Human Epileptogenic Neocortex , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] P B Hoffer,et al. Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] D E Kuhl,et al. Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[26] Christer Halldin,et al. Saturation analysis of specific 11C Ro 15‐1788 binding to the human neocortex using positron emission tomography , 1989 .
[27] C Burger,et al. Modeling alternatives for cerebral carbon-11-iomazenil kinetics. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] A. Syrota,et al. Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by positron emission tomography. , 1984, Life sciences.
[29] M. Kuhar,et al. Benzodiazepine receptor binding in vivo with [3H]-Ro 15-1788. , 1985, Life sciences.
[30] Bernard Bendriem,et al. Modeling Analysis of [11C]Flumazenil Kinetics Studied by PET: Application to a Critical Study of the Equilibrium Approaches , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[31] R H Huesman,et al. Dynamic PET Data Analysis , 1986, Journal of computer assisted tomography.
[32] J. S. Duncan,et al. Benzodiazepine Receptor Quantification in vivo in Humans Using [11C]Flumazenil and PET: Application of the Steady-State Principle , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] Robert B. Innis,et al. SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: II. Equilibrium Analysis of Constant Infusion Experiments and Correlation with in vitro Parameters , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[34] José Guimón,et al. Wavelet Analysis of Dynamic PET Data: Application to the Parametric Imaging of Benzodiazepine Receptor Concentration , 2000, NeuroImage.
[35] Robert B. Innis,et al. SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: I. Kinetic Modeling of Single Bolus Experiments , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[36] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[37] L H Staib,et al. Kinetic modeling of benzodiazepine receptor binding with PET and high specific activity [11C]Iomazenil in healthy human subjects , 2000, Synapse.